4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-016507
Chief Accounting Officer & VP sold 1,871 shares at $0.98 ($1,834)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monohon Ted Chief Accounting Officer & VP | 2023-03-06 | Sale | −1,871 | $0.98 | $1,834 | 27,440 | D |
| Open-market sales · 1,871 sh · avg $0.98 · $1,834 | |||||||
Loading xslF345X03/doc4.xml…